Kotak India Midcap C GBP Acc
Pricing frequency
Daily
Dealing cut off time
10:45
Type
SICAV
Yield
–
NAV
£29.9134
Income frequency
-
Ongoing charge
1.14%
Latest actual NAV date
13-11-2026
ISIN
LU0863494935
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 30/09/2026 | % of assets |
|---|---|
| Sansera Engineering Ltd | 4.60 |
| Shriram Finance Ltd | 4.09 |
| Eternal Ltd | 3.51 |
| Laurus Labs Ltd | 3.39 |
| TVS Motor Co Ltd | 3.07 |
| Apollo Hospitals Enterprise Ltd | 3.05 |
| Cummins India Ltd | 2.90 |
| Torrent Pharmaceuticals Ltd | 2.75 |
| Max Healthcare Institute Ltd Ordinary Shares | 2.66 |
| United Spirits Ltd | 2.56 |
Investment objective
The objective of the Sub-Fund is to achieve long term capital appreciation by investing at least two thirds of its total assets (excluding cash) in equity and equity linked securities of mid-capitalisation companies (as defined by the Investment Manager from time to time) registered in India or deriving a significant portion of their business from India. The Sub-Fund will have the flexibility to invest up to a third of its assets in equity and equity-linked instruments of large-capitalisation companies. At the time of this Prospectus, large-capitalisation companies are generally those that have a market capitalisation greater than or equal to that of the company which has the 50th largest market capitalisation amongst the companies listed in India at the time of making an investment in that company. The Sub-Fund will invest at least 50% of its total assets in equity securities.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.